Tennessee is yet another state looking to regulate hemp effectively, and a proposed solution to this is on-the-go testing kits to determine THC levels in hemp products. If executed well, this could prevent many from being charged with possession of cannabis and save money in the courts and prison systems http://bit.ly/2ISjm7V
To explore related information, click the keywords below:
Benjamin Caplan, MDRegulation of hemp in Tennessee
Genome-wide association study implicates CHRNA2 in Cannabis Use Disorder
Roughly 9% of cannabis users become dependent. In a recent study, scientists identified a significant association between CHRNA2 gene expression and a diagnosis of Cannabis Use Disorder. In other words, genetics might help to explain why some people may find themselves more dependent upon cannabis than others.
A 2019 literature review summarizes the finding on using THC and CBD on patients with dementia. Researchers found that Dronabinol and THC were associated with significant improvements in a range of psychiatric scores. Interestingly, cannabis products showed the most promising results in patients whose symptoms were previously unmanageable or resistant to other treatments.
A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain ECS
The cannabinoid system provides momentum to develop cannabinoid-based medications to treat inflammatory and neuropathic pain as researchers continue to find promising therapeutic targets. These new targets may lead to the formation of novel pain-relief medications that may serve well to alleviate pain for those suffering from cancer, multiple sclerosis, and fibromyalgia. Cannabis-based pain medicine is also being researched for opioid-sparing effects and effectiveness in reducing the necessary dose of opioids.
Many think medical marijuana laws will ultimately lead to adult-use, but this is not necessarily true, and for good reason. The medical industry recognizes that cannabis is a powerful medication and prioritizes its safety and health benefits, while so-called “recreational” or “adult use” cannabis seems to focus more on making money and supporting the pleasurable aspects of the plant.
Interestingly, at CED Clinic, we’re seeing more and more patients come in from the “adult-use.” Whether it’s a desire for comprehensive education (anything we put into our bodies has effects), personalizing a medical plan that considers short-term and long-term impact, or simply having a knowledgeable person to support individual choices and empowerment on an individual journey, we find that our patients enjoy learning and riding the cutting edge of the science of cannabis! http://bit.ly/2INDGY7
To explore related information, click the keywords below:
MA effectively outlawed the sale of any food products with CBD or products which make therapeutic claims. This is the result of FDA saying that CBD cannot be added to food or dietary supplements. In a state where cannabis is legally accessible, consumers and hemp farmers are very unhappy. What do you think? http://bit.ly/2IOtTRm
Benjamin Caplan, MDIn MA, despite being state-legal, FDA says CBD cannot be added to food or dietary supplements. What now?
Massachusetts has come one step closer to a pilot program involving cannabis cafes across the state. This will also bring about more licenses for cannabis delivery and social consumption, as a less capital-intensive option for entrepreneurs to enter the industry. http://bit.ly/2IOjOUz
To explore related information, click the keywords below:
A 2018 literature review summarizes the findings on cannabis and gut health. The endocannabinoid system plays a key role in gut motility, obesity, and inflammatory bowel disease (IBD). Targeting the endocannabinoid system with CBD oil or other cannabinoids seems to reduce colonic inflammation and relieve stress, at a microscopic level, inside the gastrointestinal tract. Watch our video adaptation of the effects of cannabis on IBD:
State laws in Florida allow card-holding seniors to use cannabis, but federally-subsidized senior homes must go against status-quo to allow this. The benefits are not being denied, but if they want to participate in Medicare then cannabis use comes with great risk. http://bit.ly/2LmKJZg
Benjamin Caplan, MDSeniors, in assisted living, and Cannabis
Some people are concerned that Cannabinoid Hyperemesis Syndrome (CHS,) a rare condition involving cyclical vomiting, may be caused by neem oil or pesticides. However, symptoms are more consistent with an overload of CB1 receptors, circumstances that occur primarily with habitual, large-volume consumers. Here, an interesting review of the ongoing public conversation: http://bit.ly/2LepwAV
To explore related information, click the keywords below:
Benjamin Caplan, MDNeem Oil vs Cannabinoid Hyperemesis Syndrome